Home > Qtrly Results > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Quarterly Results Analysis [Mar2025]

BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Quarterly Results

Consolidated Mar2025
Audited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
Audited
Dec2023
Audited
Sep2023
Audited
Jun2023
UnAudited
Revenues ₹76 Cr ₹73 Cr ₹77 Cr ₹66 Cr ₹60 Cr ₹61 Cr ₹55 Cr ₹66 Cr
Expenses ₹64 Cr ₹69 Cr ₹67 Cr ₹56 Cr ₹46 Cr ₹47 Cr ₹44 Cr ₹57 Cr
Operating Income ₹13 Cr ₹4 Cr ₹11 Cr ₹10 Cr ₹13 Cr ₹14 Cr ₹11 Cr ₹9 Cr
Other Income ₹-2 Cr ₹4 Cr ₹-4 Cr ₹-2 Cr ₹-2 Cr ₹0 Cr ₹0 Cr ₹-1 Cr
Interest ₹1 Cr ₹1 Cr ₹0 Cr ₹0 Cr ₹1 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Depreciation ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹1 Cr ₹0 Cr ₹1 Cr ₹0 Cr
Profit Before Tax ₹10 Cr ₹6 Cr ₹6 Cr ₹7 Cr ₹11 Cr ₹14 Cr ₹16 Cr ₹-39 Cr
Profit After Tax ₹9 Cr ₹5 Cr ₹5 Cr ₹6 Cr ₹11 Cr ₹14 Cr ₹14 Cr ₹-41 Cr
EPS ₹1.56 ₹0.97 ₹0.83 ₹1.17 ₹10.03 ₹2.66 ₹2.82 ₹-8.08
Industry Peers & Returns1W1M1Y
BALAXI PHARMACEUTICALS 6.8% -2.7% -48.4%
ADANI ENTERPRISES 3.1% 5.7% -17.9%
REDINGTON 3.5% 5.1% 42.7%
MMTC -4.6% 27.7% 6.3%
HONASA CONSUMER 0.2% 23.5% -27.5%
LLOYDS ENTERPRISES 12.7% 42.3% 121.7%
ENTERO HEALTHCARE SOLUTIONS -1.4% -17.2% 15.8%
OPTIEMUS INFRACOM 1.1% 10.4% 140%
POLO QUEEN INDUSTRIAL & FINTECH 0.3% -12.2% 38.8%

BALAXI PHARMACEUTICALS Quarterly Revenues

Revenues
Q-o-Q

4.06 %

Y-o-Y

27.46 %

Quarters Revenues % Change
Mar2025 ₹76 Cr
4.06
Dec2024 ₹73 Cr
-5.29
Sep2024 ₹77 Cr
17.92
Jun2024 ₹66 Cr
9.68
Mar2024 ₹60 Cr
-1.57
Dec2023 ₹61 Cr
11.08
Sep2023 ₹55 Cr
-17.03
Jun2023 ₹66 Cr -

BALAXI PHARMACEUTICALS Quarterly Operating Profit

Operating Profit
Q-o-Q

214.85 %

Y-o-Y

-6.78 %

Quarters Operating Profit % Change
Mar2025 ₹13 Cr
214.85
Dec2024 ₹4 Cr
-62.34
Sep2024 ₹11 Cr
4.97
Jun2024 ₹10 Cr
-25.10
Mar2024 ₹13 Cr
-1.42
Dec2023 ₹14 Cr
26.90
Sep2023 ₹11 Cr
21.76
Jun2023 ₹9 Cr -
Operating Margins
Q-o-Q

202.57 %

Y-o-Y

-26.88 %

Quarters Operating Margin% % Change
Mar2025 16.46%
202.57
Dec2024 5.44%
-60.23
Sep2024 13.68%
-11.00
Jun2024 15.37%
-31.72
Mar2024 22.51%
0.18
Dec2023 22.47%
14.23
Sep2023 19.67%
46.79
Jun2023 13.4% -

BALAXI PHARMACEUTICALS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

61.10 %

Y-o-Y

-20.99 %

Quarters Profit After Tax % Change
Mar2025 ₹9 Cr
61.10
Dec2024 ₹5 Cr
16.87
Sep2024 ₹5 Cr
-29.20
Jun2024 ₹6 Cr
-40.73
Mar2024 ₹11 Cr
-19.57
Dec2023 ₹14 Cr
-5.78
Sep2023 ₹14 Cr
Positive
Jun2023 ₹-41 Cr -
PAT Margins
Q-o-Q

54.78 %

Y-o-Y

-37.99 %

Quarters PAT Margin(%) % Change
Mar2025 11.33 %
54.78
Dec2024 7.32 %
23.44
Sep2024 5.93 %
-39.92
Jun2024 9.87 %
-45.98
Mar2024 18.27 %
-18.29
Dec2023 22.36 %
-15.21
Sep2023 26.37 %
Positive
Jun2023 -62.68 % -

BALAXI PHARMACEUTICALS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

60.82 %

Y-o-Y

-84.45 %

Quarters EPS % Change
Mar2025 ₹1.56
60.82
Dec2024 ₹0.97
16.87
Sep2024 ₹0.83
-29.06
Jun2024 ₹1.17
-88.33
Mar2024 ₹10.03
277.07
Dec2023 ₹2.66
-5.67
Sep2023 ₹2.82
Positive
Jun2023 ₹-8.08 -

You may also like the below Video Courses